Search by Drug Name or NDC

    NDC 00113-1913-30 good sense mucus relief cold flu and sore throat 650; 20; 400; 10 mg/20mL; mg/20mL; mg/20mL; mg/20mL Details

    good sense mucus relief cold flu and sore throat 650; 20; 400; 10 mg/20mL; mg/20mL; mg/20mL; mg/20mL

    good sense mucus relief cold flu and sore throat is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by L. Perrigo Company. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 00113-1913
    Product ID 0113-1913_ecabb6b9-e23b-45f9-9ff0-d9e4e2617e89
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name good sense mucus relief cold flu and sore throat
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 20; 400; 10
    Active Ingredient Units mg/20mL; mg/20mL; mg/20mL; mg/20mL
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name L. Perrigo Company
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00113-1913-30 (00113191330)

    NDC Package Code 0113-1913-30
    Billing NDC 00113191330
    Package 180 mL in 1 BOTTLE (0113-1913-30)
    Marketing Start Date 2020-10-03
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL ecabb6b9-e23b-45f9-9ff0-d9e4e2617e89 Details

    Revised: 10/2020